GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.8477 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.8477 |
[BP] GO:0007187 |
None
|
CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
10.2674 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX15, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
9.37048 |
[BP] GO:0097756 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
8.10222 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HTR1B, HTR5A, MMP2, MMP9, PIK3CA, PPARA, PTGS2 |
7.77643 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB |
7.74685 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, MMP2, MMP9, PIK3CA, PPARA, PTGS2 |
7.52898 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
7.46101 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
7.09291 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
6.83075 |
[BP] GO:0007188 |
None
|
CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
6.80637 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.80637 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.80637 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CNR1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HTR1B, HTR5A, PTGS2 |
6.77545 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
6.7476 |
[BP] GO:0050795 |
None
|
CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
6.7476 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, PTGS2 |
6.73213 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD11B1, HSD11B2, HTR1A, HTR2A, HTR2C |
6.6626 |
[BP] GO:0007193 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
6.27129 |
[BP] GO:0097746 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.27129 |
[BP] GO:0035296 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.27129 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
6.11504 |
[BP] GO:0050880 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.08604 |
[BP] GO:0035150 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.06992 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
5.91871 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.83553 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.83553 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX15, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, FDPS, FUT7, HSD11B1, HSD11B2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
5.73541 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, CNR1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.73541 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, CNR1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.73541 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D |
5.67989 |
[BP] GO:0003018 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.63049 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD11B2, HTR1B, HTR5A, MMP2, PIK3CA, PPARA, PTGS2 |
5.59181 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
CNR1, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.4734 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX15, ALPL, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F10, F3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, MMP1, MMP2, MMP9, PIK3CA, PPARA, PTGS2 |
5.47269 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CYP1A1, CYP3A4, FDPS, HSD11B1, HSD11B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.36377 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F10, F3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
5.19613 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, AOX1, CA12, CA2, CA4, CA7, CA9, CYP1A1, CYP1B1, CYP3A4, FDPS, FUT7, HTR2B, HTR2C, PIK3CA, PPARA, PTGS1, PTGS2 |
5.16 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2 |
5.11011 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CNR1, CNR2, CYP1A1, ESR1, ESRRA, HSD11B2, HTR1B, HTR5A, PTGS2 |
5.08907 |
[BP] GO:0007154 |
None
|
BCL2, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
5.06199 |
[BP] GO:0032844 |
regulation of homeostatic process
|
BCL2, CA2, CA7, CNR1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, PIK3CB, PTGS2 |
5.0496 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.97482 |
[BP] GO:0007267 |
None
|
CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.83476 |
[BP] GO:0003013 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.81416 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, HTR2A, HTR2B, HTR2C |
4.77125 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.72311 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, BCL2, CA2, CA7, CYP1B1, DRD1, DRD2, F10, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2 |
4.71161 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, BCL2, CA2, CA7, CYP1B1, DRD1, DRD2, F10, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2 |
4.69037 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, DRD2, HTR1B, HTR2A, MMP9, PTGS2 |
4.69037 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
4.68084 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, ESR1, ESRRA, HSD11B2, HTR1B, HTR5A, PPARA, PTGS2 |
4.63756 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, BCL2, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, FDPS, HTR1A |
4.62824 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
4.60332 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
4.58089 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CYP1B1, DRD2, F10, F3, HTR2A, HTR2B, HTR2C, HTR6, PIK3CA, PIK3CB, PTGS2 |
4.53944 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
4.52846 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, DRD1, ESR1, ESRRA, HSD11B2, HTR1B, HTR5A, MMP2, PPARA, PTGS2 |
4.51132 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CNR2, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2 |
4.44081 |
[BP] GO:0023052 |
None
|
CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.41926 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, BCL2, CA2, CNR1, CNR2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, MMP9, PIK3CA, PIK3CB, PPARA |
4.41926 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.41608 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CNR2, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2 |
4.36427 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP1A1, CYP1B1, CYP3A4, ESR1, FDPS, HSD11B1, HSD11B2 |
4.31072 |
[BP] GO:0003008 |
None
|
AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA, PTGS2 |
4.29811 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, PTGS1, PTGS2 |
4.2231 |
[BP] GO:0043269 |
regulation of ion transport
|
BCL2, CA2, CA7, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 |
4.12855 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2 |
4.11798 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
4.09958 |
[BP] GO:0090066 |
None
|
ALOX15, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.08845 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.92961 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.92017 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.85163 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, CYP1A1, CYP1B1, CYP3A4, DRD2, FDPS, FUT7, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
3.8371 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.80915 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, ALOX15, BCL2, CA2, CA7, CNR1, CYP1B1, DRD1, DRD2, F10, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2 |
3.80113 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.76438 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.69985 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.69985 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, BCL2, CA2, CYP1A1, DRD1, DRD2, HSD11B2, HTR1B, HTR2A, HTR2B, MMP2, PPARA, PTGS2 |
3.66731 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
3.6483 |
[BP] GO:0006936 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.63371 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, ALOX15, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR2C, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
3.63297 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.60535 |
[BP] GO:0071073 |
None
|
HTR2A, HTR2B, HTR2C |
3.60535 |
[BP] GO:0051952 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A |
3.56226 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
3.56226 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.55372 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A |
3.51313 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, CNR1, DRD1, DRD2, PIK3CB, PTGS2 |
3.5047 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.46916 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, DRD2, ESR1, F3, HTR1A, HTR1B, HTR2A, HTR2B, MMP2, MMP9, PTGS2 |
3.46738 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, BCL2, CYP1B1, DRD2, ESR1, ESRRA, F3, HTR1A, HTR1B, HTR2A, HTR2B, MMP2, MMP9, PTGS1, PTGS2 |
3.46272 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, BCL2, CA2, CA7, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2 |
3.43178 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
3.42486 |
[BP] GO:0008217 |
None
|
CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2 |
3.41993 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CA2, CYP1A1, CYP1B1, DRD2, MMP9, PTGS2 |
3.38709 |
[BP] GO:0002031 |
None
|
DRD2, HTR1B, HTR2B |
3.36203 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, PPARA |
3.3532 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A |
3.26922 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR2C |
3.24845 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CNR1, CYP1A1, FDPS, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.20959 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.2048 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, BCL2, CYP1B1, DRD2, F10, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2 |
3.19653 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, BCL2, CNR1, CYP1B1, DRD2, ESRRA, F10, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2 |
3.18698 |
[BP] GO:0019725 |
cellular homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.18522 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.17203 |
[BP] GO:0003012 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.12052 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, PTGS1, PTGS2 |
3.11293 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.09435 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
3.09115 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
3.09115 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.08862 |
[BP] GO:0051967 |
None
|
DRD2, HTR1B, HTR2A |
3.07013 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, PTGS1, PTGS2 |
3.06566 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.06118 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX15, BCL2, CA2, CA7, CNR1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2 |
3.04946 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.04334 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
3.04334 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
3.02392 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CYP1A1, CYP1B1, PTGS1, PTGS2 |
3.01288 |
[BP] GO:0016477 |
cell migration
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, MMP1, MMP9, PIK3CA, PIK3CB |
2.99823 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, PTGS2 |
2.99823 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.9972 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, BCL2, CYP1B1, DRD2, ESR1, F10, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2 |
2.97802 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP1A1, CYP1B1, CYP3A4, ESR1 |
2.95119 |
[BP] GO:0071071 |
None
|
HTR2A, HTR2B, HTR2C |
2.94189 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.94189 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1B1 |
2.9372 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
2.92438 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, HTR2C |
2.86804 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.86788 |
[BP] GO:0015711 |
organic anion transport
|
CA12, CA14, CA2, CA4, CA7, CA9, DRD2, PPARA |
2.86788 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.85933 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1B1, CYP3A4, NQO2, PTGS1 |
2.85933 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.85484 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.82531 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, DRD1, DRD2, HTR2A, PIK3CA |
2.79379 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.768 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, AOX1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD11B2, NQO2, PTGS1, PTGS2 |
2.75911 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
CA2, CA7, DRD1, DRD2, PTGS2 |
2.74805 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
2.71818 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, DRD2, MMP9, PTGS2 |
2.7001 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A |
2.68049 |
[BP] GO:0048870 |
cell motility
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, MMP1, MMP9, PIK3CA, PIK3CB |
2.68049 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP3A4, FDPS, HSD11B1, HSD11B2 |
2.68049 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, BCL2, DRD1, DRD2, ESRRB, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2 |
2.68049 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, BCL2, DRD1, DRD2, ESRRB, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2 |
2.68049 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP3A4, HSD11B1, HSD11B2 |
2.68049 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.68049 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.67271 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.67271 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
2.67271 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, HSD11B2, HTR1B, PTGS2 |
2.6518 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
2.64718 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.64685 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, BCL2, DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2 |
2.64685 |
[BP] GO:0046889 |
None
|
HTR2A, HTR2B, HTR2C, PTGS2 |
2.62983 |
[BP] GO:0060402 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.62983 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.62983 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, BCL2, DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2 |
2.61393 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9 |
2.60114 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX15, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F10, F3, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2 |
2.55175 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.49622 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.49622 |
[BP] GO:1900543 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.46946 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HTR2A, HTR2B, HTR2C |
2.46167 |
[BP] GO:0045980 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.44942 |
[BP] GO:0090407 |
organophosphate biosynthetic process
|
ACHE, ALOX15, FDPS, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2 |
2.44876 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, BCL2, DRD2, ESRRB, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2 |
2.44529 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, HTR1B |
2.44084 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.42209 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.42209 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.41214 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
2.41214 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.40309 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.40068 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, BCL2, CA2, CA9, CNR1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FUT7, HSD11B1, HTR2A, HTR2B, HTR5A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2 |
2.39014 |
[BP] GO:0060401 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.38177 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, HTR1A, PTGS2 |
2.34504 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, HTR1B, MMP2, PIK3CA, PTGS2 |
2.34504 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, HSD11B2, HTR1B, PTGS2 |
2.34504 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CYP1A1, CYP1B1, PTGS1, PTGS2 |
2.34504 |
[BP] GO:0040011 |
locomotion
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, MMP1, MMP9, PIK3CA, PIK3CB |
2.33998 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.28737 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.28666 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2 |
2.28598 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.24305 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.24305 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.24305 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.24305 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, HTR1B |
2.22018 |
[BP] GO:0001659 |
None
|
DRD1, DRD2, HTR2A |
2.22018 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.22018 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.21943 |
[BP] GO:0046890 |
None
|
FDPS, HTR2A, HTR2B, HTR2C, PTGS2 |
2.21943 |
[BP] GO:0006820 |
anion transport
|
CA12, CA14, CA2, CA4, CA7, CA9, DRD2, PPARA |
2.21222 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.21222 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, HTR1B, MMP2, MMP9, PIK3CA, PTGS2 |
2.18844 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.18844 |
[BP] GO:0060359 |
None
|
CNR1, DRD1, DRD2, HTR1B |
2.17814 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, BCL2, CYP1B1, DRD1, DRD2, F10, F3, HTR1D, MMP9, PTGS2 |
2.16964 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B |
2.15286 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, BCL2, DRD1, DRD2, ESRRB, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2 |
2.14083 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.14012 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.13022 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, AOX1, BCL2, CA12, CA2, CA4, CA7, CA9, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FDPS, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR2B, HTR2C, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
2.11316 |
[BP] GO:0006811 |
None
|
CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, HTR2A, HTR2B, HTR2C, PPARA |
2.11087 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, ALOX15, BCL2, CA12, CA2, CA7, CA9, CNR1, CNR2, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FDPS, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
2.10923 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.10923 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.10923 |
[BP] GO:0014831 |
None
|
HTR1D, HTR2B |
2.10923 |
[BP] GO:0032229 |
None
|
CNR2, HTR1B |
2.10923 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.10923 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.10923 |
[BP] GO:0021885 |
forebrain cell migration
|
DRD1, DRD2, HTR6 |
2.09967 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, DRD1, DRD2, HTR1A |
2.08102 |
[BP] GO:0007631 |
None
|
DRD1, DRD2, HTR1B, HTR2C |
2.08102 |
[BP] GO:0043112 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.08102 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B |
2.06893 |
[BP] GO:0003014 |
None
|
AKR1B1, BCL2, DRD2, HSD11B2 |
2.06702 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1B1, PPARA, PTGS1, PTGS2 |
2.06702 |
[BP] GO:0060135 |
None
|
AKR1B1, CNR1, ESR1 |
2.03916 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.03916 |
[BP] GO:0006954 |
inflammatory response
|
ADORA3, ALOX15, CNR2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.03486 |
[BP] GO:0006952 |
defense response
|
ADORA3, ALOX15, BCL2, CNR2, DRD1, HTR1A, HTR2C, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.03486 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, CYP1A1, CYP3A4, FDPS, PTGS1, PTGS2 |
2.01196 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2 |
2.01181 |
[BP] GO:0007566 |
embryo implantation
|
MMP2, MMP9, PTGS2 |
2.01181 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, CA4, CNR1, CNR2, DRD1, DRD2, F10, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
6.09303 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ALOX15, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.84502 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, ALOX15, ALPL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, ESR1, F10, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB |
5.22721 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, ALOX15, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, F10, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTGS2 |
4.91669 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX15, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.58369 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
4.2231 |
[CC] GO:0031224 |
None
|
ACHE, ADORA3, ALPL, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FUT7, HSD11B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
2.71818 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.68049 |
[CC] GO:0120025 |
None
|
AKR1B1, CA2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2 |
2.10466 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.8477 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
18.8477 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
18.3153 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
18.3153 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.4189 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.4161 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
15.065 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
14.7384 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
12.8254 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, AOX1, CA12, CA14, CA2, CA4, CA7, CA9, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, FDPS, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2 |
11.0467 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
9.03613 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
8.83109 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALPL, AOX1, CA12, CA14, CA2, CA4, CA7, CA9, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FDPS, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
8.43007 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, AOX1, CA12, CA2, CA4, CA7, CA9, CYP1A1, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PPARA |
8.10222 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
8.10222 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
7.85556 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
7.38275 |
[MF] GO:0004930 |
None
|
ADORA3, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
6.73105 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.63049 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD2, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
5.54572 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, CNR1, CNR2, DRD1, DRD2, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
5.54572 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NQO2, PPARA |
5.39094 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.91845 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2 |
4.62824 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.41608 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.41608 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.04922 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, AOX1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD11B2, NQO2, PTGS1, PTGS2 |
3.46272 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.04334 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.04334 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
3.04334 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
3.04334 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, AOX1, CA12, CA14, CA2, CA4, CA7, CA9, CYP1A1, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, FDPS, MMP1, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2 |
3.02579 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, HSD11B2, PPARA |
2.99823 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.9942 |
[MF] GO:0008144 |
drug binding
|
ACHE, CNR1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HTR1B, HTR2A, HTR2B, HTR2C, NQO2, PIK3CA, PIK3CB, PPARA |
2.67271 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.67271 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.67271 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.67271 |
[MF] GO:0020037 |
heme binding
|
CYP1A1, CYP1B1, CYP3A4, PTGS1, PTGS2 |
2.67271 |
[MF] GO:0070330 |
aromatase activity
|
CYP1A1, CYP1B1, CYP3A4 |
2.54534 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP1A1, CYP1B1, CYP3A4, PTGS1, PTGS2 |
2.54034 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP1A1, CYP1B1, CYP3A4, HSD11B2, NQO2, PTGS1, PTGS2 |
2.50627 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.42209 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP1A1, CYP1B1, CYP3A4 |
2.41214 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP1A1, CYP1B1, CYP3A4, PTGS1, PTGS2 |
2.34504 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, AOX1, CYP1A1, CYP1B1, CYP3A4 |
2.28666 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.24305 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.24305 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP2, MMP9 |
2.14209 |